Sarepta Therapeutics | Passivo Circulante



Current Liabilities Alterar Data
Acadia Pharmaceuticals USD 330.02M 27.49M 2025-06
Agios Pharmaceuticals USD 70.41M 18.04M 2025-06
Alnylam Pharmaceuticals USD 1.3B 225.22M 2025-06
Amgen USD 20.48B 2.53B 2025-06
Biogen USD 3.18B 2.11B 2025-06
BioMarin Pharmaceutical USD 684.25M 56.03M 2025-06
Daiichi Sankyo JPY 799.97B 45.94B 2025-06
Eli Lilly USD 39.02B 8.95B 2025-06
Gilead Sciences USD 11.19B 1.15B 2025-06
Incyte USD 1.28B 608.18M 2025-06
Insmed USD 311.68M 72.45M 2025-06
Ionis Pharmaceuticals USD 897.24M 646.94M 2025-06
Moderna USD 1.57B 32M 2025-06
Neurocrine Biosciences USD 546.3M 23.4M 2025-06
Pfizer USD 37.73B 1.27B 2025-06
PTC Therapeutics USD 627.81M 32.42M 2025-06
Regeneron Pharmaceuticals USD 3.67B 100.4M 2025-06
Roche Holding CHF 27.02B 424M 2024-12
Sanofi 29.06B 3.16B 2025-06
Sarepta Therapeutics USD 919.95M 314.36M 2025-06
Tectonic Therapeutic USD 11.61M 5.71M 2024-12
Ultragenyx Pharmaceutical USD 293.24M 1.58M 2025-06
Vertex Pharmaceuticals USD 4.14B 355.2M 2025-06


Sarepta Therapeutics Passivo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Aug 2025.